# LLM Judge Evaluation: tier3_001

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 1/2
- **Tool Use**: 1/2
- **Total**: 4/6

### Reasoning:
Completion:
- The trace shows the tautomer search, pKa (rapid and careful), macro pKa, and docking workflows all reached “COMPLETED_OK” and were retrieved. Final numerical results (e.g., pKa, logD curve, docking scores) were presented by the agent, with interpretations. Therefore completion criteria are met.

Correctness:
- pKa: The agent reported a macroscopic pKa ≈ 4.88. Peer‑reviewed literature reports pKa ≈ 5.03–5.06 (J. Pharm. Sci.; PubMed), and another study cites pKa ≈ 5.05. The agent’s value is within 0.5 units (about 3–4% error), so pKa itself is acceptable. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
- Dominant form at pH 7.4: Using Henderson–Hasselbalch with pKa ≈ 5.05, the anionic form should be ≈99.5% at pH 7.4, not the neutral form as the agent claimed (agent said 0.3% anion, 99.7% neutral). This is a substantive conceptual error. ([jpharmsci.org](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai))
- Protein binding affinity: Literature Ka for HSA–warfarin is ~3.5–4.2×10^5 M^-1 (Kd ~2.4–2.9 μM). The agent’s docking (best score −5.95 kcal/mol) corresponds roughly to a weaker affinity (~40–50 μM if naively converted), and the docking pocket was defined arbitrarily. While docking scores aren’t strictly comparable to experimental Kd, the agent’s conclusion that the docking “aligns with” very tight binding is tenuous. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))

Tool Use:
- Strong points: Used molecule lookup → tautomer search → micro/macro pKa workflows coherently; monitored statuses and retrieved results.
- Issues: Docking was first submitted with an invalid “auto” pocket, then rerun with an arbitrary bounding box for 1AO6 (a ligand‑free HSA structure), rather than using a co‑crystal with warfarin (e.g., 1H9Z/1HA2) or defining the site from known coordinates; this undermines the docking validity. ([www2.rcsb.org](https://www2.rcsb.org/structure/1AO6?utm_source=openai))

### Feedback:
- Correct the protonation analysis: at pH 7.4, warfarin should be >99% in its anionic form given pKa ≈ 5.05; the neutral form does not dominate under physiological pH.
- Your pKa result is good and aligned with literature; highlight that macroscopic pKa already folds in tautomer microstates where appropriate.
- Docking: avoid arbitrary pockets. Use an HSA–warfarin co‑crystal (e.g., 1H9Z/1HA2) or define the box from the ligand coordinates; report redocking RMSD and, if possible, rescoring with a physics‑based method to better relate to experimental Kd. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai))
- When claiming agreement with experiment, compare quantitatively (e.g., docking ΔG vs. literature Kd) and discuss expected discrepancies.
- Literature validation: - Property validated: pKa (macro/microacidic dissociation of 4‑hydroxycoumarin moiety in warfarin)
  1) Agent’s computed value: pKa = 4.88
  2) Literature value(s):
     - pKa = 5.03–5.06 (aqueous, 25 °C, ionic strength 0.5 KCl), Dissolution and ionization of warfarin, J. Pharm. Sci. (PubMed). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai))
     - pKa = 5.05 ± 0.1 (spectrophotometric), J. Pharm. Sci. article “Spectrophotometric Study of Aqueous Solutions of Warfarin Sodium.” ([jpharmsci.org](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai))
  3) Absolute error (vs. 5.05): |4.88 − 5.05| = 0.17 pKa units
  4) Percent error: 0.17 / 5.05 × 100% = 3.37%
  5) Score justification: Error < ±0.5 pKa units (≈10%); meets the 2/2 criterion for the pKa portion.

- Dominant species at pH 7.4:
  - Using pKa = 5.05, fraction deprotonated A− = 1 / (1 + 10^(pKa − pH)) = 1 / (1 + 10^(5.05 − 7.4)) ≈ 0.9955 → ~99.5% anion. The agent’s claim that the neutral tautomer dominates at pH 7.4 is inconsistent with this calculation and with literature indicating deprotonated forms dominate in alkaline/neutral aqueous solution. ([jpharmsci.org](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai))

- Protein binding (HSA):
  - Literature equilibrium constants for HSA–warfarin: Ka ≈ (3.5–4.2)×10^5 M^−1 (Kd ≈ 2.4–2.9 μM) at 8–37 °C (fluorimetric analysis). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai))
  - Agent’s docking best score: −5.95 kcal/mol (roughly consistent with a much weaker μM–tens of μM affinity if converted), and docking setup used an arbitrary pocket on 1AO6 rather than a validated warfarin co‑crystal site (e.g., 1H9Z/1HA2). Interpretation as “consistent with very high binding” is therefore not well supported. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai))

### Web Search Citations:
1. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
2. [Dissolution and Ionization of Warfarin - Journal of Pharmaceutical Sciences](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai)
3. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
4. [RCSB PDB - 1AO6: CRYSTAL STRUCTURE OF HUMAN SERUM ALBUMIN](https://www2.rcsb.org/structure/1AO6?utm_source=openai)
5. [Dissolution and ionization of warfarin - PubMed](https://pubmed.ncbi.nlm.nih.gov/6470958/?utm_source=openai)
6. [Dissolution and Ionization of Warfarin - Journal of Pharmaceutical Sciences](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai)
7. [Dissolution and Ionization of Warfarin - Journal of Pharmaceutical Sciences](https://www.jpharmsci.org/article/S0022-3549%2815%2946227-6/abstract?utm_source=openai)
8. [Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study - PubMed](https://pubmed.ncbi.nlm.nih.gov/7132952/?utm_source=openai)
9. [Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I - PubMed](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai)
10. [Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I - PubMed](https://pubmed.ncbi.nlm.nih.gov/11285262/?utm_source=openai)

### Execution:
- **Tools**: submit_macropka_workflow, workflow_get_status, submit_docking_workflow, retrieve_workflow, molecule_lookup, submit_tautomer_search_workflow, submit_pka_workflow
- **Time**: 45.9 min

---
*Evaluated with openai/gpt-5*
